| Product Code: ETC9959550 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Artificial Blood Substitutes Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Artificial Blood Substitutes Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Artificial Blood Substitutes Market - Industry Life Cycle |
3.4 United States (US) Artificial Blood Substitutes Market - Porter's Five Forces |
3.5 United States (US) Artificial Blood Substitutes Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Artificial Blood Substitutes Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 United States (US) Artificial Blood Substitutes Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United States (US) Artificial Blood Substitutes Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Artificial Blood Substitutes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of chronic diseases requiring blood transfusions |
4.2.2 Technological advancements in artificial blood substitute products |
4.2.3 Increasing demand for blood transfusion alternatives due to blood shortages |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of artificial blood substitutes |
4.3.2 High cost associated with development and manufacturing of artificial blood substitutes |
4.3.3 Potential safety concerns and side effects associated with artificial blood substitutes |
5 United States (US) Artificial Blood Substitutes Market Trends |
6 United States (US) Artificial Blood Substitutes Market, By Types |
6.1 United States (US) Artificial Blood Substitutes Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Perflurocarbon (PFCs), 2021- 2031F |
6.1.4 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Hemoglobin-Based Oxygen Carries (HBOCs), 2021- 2031F |
6.2 United States (US) Artificial Blood Substitutes Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Human Blood, 2021- 2031F |
6.2.3 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Animal Blood, 2021- 2031F |
6.2.4 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Microorganism Based Recombinant HB, 2021- 2031F |
6.2.5 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Synthetic Polymers, 2021- 2031F |
6.2.6 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Stem Cells, 2021- 2031F |
6.3 United States (US) Artificial Blood Substitutes Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Malignant Neoplasma, 2021- 2031F |
6.3.4 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Injuries, 2021- 2031F |
6.3.5 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Neonatal Conditions, 2021- 2031F |
6.3.6 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Organ Transplant, 2021- 2031F |
6.3.7 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Maternal Condition, 2021- 2031F |
6.4 United States (US) Artificial Blood Substitutes Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Hospital and Clinics, 2021- 2031F |
6.4.3 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Blood Banks, 2021- 2031F |
6.4.4 United States (US) Artificial Blood Substitutes Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Artificial Blood Substitutes Market Import-Export Trade Statistics |
7.1 United States (US) Artificial Blood Substitutes Market Export to Major Countries |
7.2 United States (US) Artificial Blood Substitutes Market Imports from Major Countries |
8 United States (US) Artificial Blood Substitutes Market Key Performance Indicators |
8.1 Research and development investment in artificial blood substitute technologies |
8.2 Number of clinical trials and regulatory approvals for artificial blood substitute products |
8.3 Adoption rate of artificial blood substitutes in healthcare facilities |
9 United States (US) Artificial Blood Substitutes Market - Opportunity Assessment |
9.1 United States (US) Artificial Blood Substitutes Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Artificial Blood Substitutes Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 United States (US) Artificial Blood Substitutes Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United States (US) Artificial Blood Substitutes Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Artificial Blood Substitutes Market - Competitive Landscape |
10.1 United States (US) Artificial Blood Substitutes Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Artificial Blood Substitutes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here